CATX - Perspective Therapeutics, Inc.

4.97
-0.130   -2.616%

Share volume: 1,053,692
Last Updated: 03-06-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.03%

PREVIOUS CLOSE
CHG
CHG%
$5.10
-0.13
-0.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
34%
Profitability 35%
Dept financing 24%
Liquidity 57%
Performance 30%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-7.10%
1 Month
2.69%
3 Months
107.08%
6 Months
44.90%
1 Year
90.42%
2 Year
368.87%
Key data
Stock price
$4.97
P/E Ratio 
0.00
DAY RANGE
$4.77 - $5.05
EPS 
-$1.51
52 WEEK RANGE
$1.60 - $6.16
52 WEEK CHANGE
$95.67
MARKET CAP 
254.722 M
YIELD 
N/A
SHARES OUTSTANDING 
74.338 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-14-2025
BETA 
0.75
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$1,350,797
AVERAGE 30 VOLUME 
$1,842,333
Company detail
CEO: Lori A. Woods
Region: US
Website: isoray.com
Employees: 70
IPO year: 2007
Issue type: Common Stock
Market: NYSE American
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

Isoray, Inc. develops, manufactures, and sells isotope-based medical products and devices. CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities.

Recent news